2021
DOI: 10.3390/antibiotics10010056
|View full text |Cite
|
Sign up to set email alerts
|

Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates: In Vivo Virulence Assessment in Galleria mellonella and Potential Therapeutics by Polycationic Oligoethyleneimine

Abstract: Klebsiella pneumoniae, one of the most common pathogens found in hospital-acquired infections, is often resistant to multiple antibiotics. In fact, multidrug-resistant (MDR) K. pneumoniae producing KPC or OXA-48-like carbapenemases are recognized as a serious global health threat. In this sense, we evaluated the virulence of K. pneumoniae KPC(+) or OXA-48(+) aiming at potential antimicrobial therapeutics. K. pneumoniae carbapenemase (KPC) and the expanded-spectrum oxacillinase OXA-48 isolates were obtained fro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
14
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 52 publications
(39 reference statements)
0
14
0
Order By: Relevance
“…Infections with MDR organisms or the rising, extensive, drug-resistant Gram-negative bacteria including the carbapenem-resistant Enterobacteriaceae (CRE) and extended-spectrum β-lactamase (ESBL) producers remain the most challenging. This is because of their limited treatment options, their rapid spread among healthcare environments causing outbreaks associated with high mortality rates and their associated prolonged hospital stays with a high economic burden [ 2 , 3 , 4 ]. It is also estimated that by 2030, more than half of Klebsiella pneumoniae and Escherichia coli will be resistant to third-generation cephalosporins [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…Infections with MDR organisms or the rising, extensive, drug-resistant Gram-negative bacteria including the carbapenem-resistant Enterobacteriaceae (CRE) and extended-spectrum β-lactamase (ESBL) producers remain the most challenging. This is because of their limited treatment options, their rapid spread among healthcare environments causing outbreaks associated with high mortality rates and their associated prolonged hospital stays with a high economic burden [ 2 , 3 , 4 ]. It is also estimated that by 2030, more than half of Klebsiella pneumoniae and Escherichia coli will be resistant to third-generation cephalosporins [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…Antimicrobial polymers have been shown to be promising alternatives to combat microorganisms [ 105 , 106 ]. In particular, cationic polymers have been widely explored and shown to be highly efficient in killing both Gram-positive and Gram-negative bacteria [ 105 , 107 ].…”
Section: Antibacterial and Antibiofilm Strategiesmentioning
confidence: 99%
“…Molecular weight might influence diffusion of polymers across lipid membrane and contribute to bacterial cell death. To mimic AMP mechanism, the synthesis of polymers often includes a cationic group to interact with negative membrane of bacterial cells [ 106 , 108 , 109 , 110 ]. Quaternary ammonium groups or quaternary phosphonium group has been explored as a cationic core in new synthetic polymers [ 110 ].…”
Section: Antibacterial and Antibiofilm Strategiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Using a different approach, Mil-Homens et al reported the application of a synthetic polycationic oligomer (L-OEI-h) as an alternative to treat Klebsiella pneumoniae infections [13]. The authors showed that L-OEI-h caused lysis of the cytoplasmic membrane in a panel of different species.…”
mentioning
confidence: 99%